Nonetheless, current clinical practice in managing T2DM using GLP-1RAs is likely to vary worldwide due to differences in healthcare systems and their accessibility, in the availability and affordability of medications, as well as in country-specific reimbursement policies
[8] [9] Dulaglutide (Trulicity) is FDA-approved only for type 2 diabetes management, not for weight loss
Lee, K-A., Flores, RR., Jang, IH., Saathoff, A
It is a necessity
High serum iron and zinc decrease glutathione S-transferase among women with breast cancer Main Article Content Abstract Breast cancer in Indonesia ranks second as the most common cancer found in women after cervical cancer
Now back to this, GLP-1 hormone, which is the star of the drug